TechnologyPatent OppositionCompetitive Analysis

Explore the competitive field of Digestive Drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in Digestive Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Digestive Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Digestive Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Digestive Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Digestive Drugs industry

Therapeutic Agent And Therapeutic Method For Pulmonary HypertensionKYOWA KIRINJul 16, 2025J A KEMP
Therapeutic Agent And Therapeutic Method For Pulmonary HypertensionUNIVERSITY OF TOYAMAJul 15, 2025ALTMANN STOSSEL DICK PATENTANWALTE PARTG MBB
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSJul 9, 2025TEVA PHARMACEUTICALS
Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9)REGENERON PHARMACEUTICALSJun 23, 2025AMGEN
Sex Sorted Sperm Demonstrating A Dose Response And Methods Of Producing Sex Sorted Sperm Demonstrating A Dose ResponseINGURANJun 18, 2025ABS
Use Of Substituted Aminopropionate Compounds In Treatment Of Sars-Cov-2 InfectionACADEMY OF MILITARY MEDICAL SCIENCESJun 18, 2025GILEAD SCIENCES
Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTISMay 21, 2025HAMPTON KNOWLES
Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTISMay 20, 2025NEUEFEIND
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025TEVA PHARMACEUTICALS
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 6, 2025SANDOZ

To stay ahead in the competitive Digestive Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Digestive Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY22
Aug 18, 2021Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS11
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUP8
Nov 14, 2018Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM8
Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS8
Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS7
Aug 21, 2024Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTIS7
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS7
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS7